Nov 26, 2024 | News
Calgary, Alberta – November 26, 2024 – Marvel Biosciences Corp. (TSXV: MRVL OTC: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), is pleased to share additional data from its ongoing preclinical Rett syndrome...
Nov 21, 2024 | News
Calgary, Alberta – November 21, 2024 – Marvel Biosciences Corp. (TSXV: MRVL OTC: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), today is pleased to announce it has been awarded the Alberta Innovates AICE...
Nov 14, 2024 | News
CALGARY, Alberta, Nov. 13, 2024 (GLOBE NEWSWIRE) – Marvel Biosciences Corp.(TSX:V MBCOF:OTC), based in Calgary, Alberta, focused on Alzheimer’s Disease, Depression and Autism today announced that Dr. Mark Williams, CSO will present live at the Life Sciences...
Nov 7, 2024 | News
Calgary, Alberta – November 7, 2024 – Marvel Biosciences Corp. (TSXV: MRVL OTC: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), today reported promising interim results from its study on MB204, as a...
Oct 10, 2024 | News
Calgary, Alberta – October 10, 2024 – Marvel Biosciences Corp. (TSXV: MRVL OTC: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), today shared promising results from a recent study on MB204. The research was...
Aug 13, 2024 | News
Calgary, Alberta – August 13, 2024 – Marvel Biosciences Corp. (TSXV: MRVL OTC: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), is pleased to announce it has entered a collaboration with the FRAXA Research...
